Skip to main content
Clinical Trials/KCT0001500
KCT0001500
Completed
未知

Population pharmacokinetics and pharmacodynamics of ramosetron

Asan Medical Center0 sites51 target enrollmentTBD
ConditionsNot Applicable

Overview

Phase
未知
Intervention
Not specified
Conditions
Not Applicable
Sponsor
Asan Medical Center
Enrollment
51
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) American Society of Anesthesiologists (ASA) physical status 1 or 2
  • 2\) Age over 20
  • 3\) Patients scheduled for elective surgery under general anesthesia
  • 4\) Patients who volunteered
  • 5\) Patients who have more than 2 factors of Apfel's PONV risk factor
  • 6\) Patients scheduled for elective stomach, colorectal surgery under laparotomy or laparoscopy

Exclusion Criteria

  • 1\) Age less than 20
  • 2\) History of anaphylactic response to fentanyl, ketorolac, or ramosetron
  • 3\) Patients who received antiemetics, steroids, antihistamines, or antipsychotic drugs that can affect PONV, within 24 hours before surgery
  • 4\) ASA physical status over 3
  • 5\) Patients planned for maintaning nasogastric tube postoperatively
  • 6\) Patients with hemoglobin level less than 10\.0 g/dl preoperatively
  • 7\) Patients who participated in clinical trial on other drugs, within 30 days before screening
  • 8\) Patients who donated blood over 450 ml, within 30 days before screening
  • 9\) Active hepatitis (HIV postitive, history of HBV, HCV, and positive on serologic tests)
  • 10\) Binge drinking\* or clinically significant alcoholics\*\*

Outcomes

Primary Outcomes

Not specified

Similar Trials